Medical College of Georgia Infectious Disease

Topics

• Antifungal resistance and susceptibility 133
• HIV/AIDS drug development and treatment 28
• HIV Research and Treatment 14
• Fungal Infections and Studies 13
• HIV-related health complications and treatments 10
• HIV/AIDS oral health manifestations 9
• Pneumocystis jirovecii pneumonia detection and treatment 8
• Antimicrobial Resistance in Staphylococcus 7
• Infective Endocarditis Diagnosis and Management 7
• Apelin-related biomedical research 6
• Atrial Fibrillation Management and Outcomes 6
• Cardiac electrophysiology and arrhythmias 6

Most cited

1. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.

   Intensive care medicine · 2024 · 170 citations · Jose Vazquez

2. Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.

   The Lancet. Infectious diseases · 2025 · 69 citations · Jose Vazquez

3. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.

   Lancet (London, England) · 2023 · 154 citations · Jose Vazquez

4. EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group.

   Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021 · 259 citations · Jose Vazquez

5. Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials.

   The Lancet. Infectious diseases · 2024 · 70 citations · Jose Vazquez

6. Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris: Results from a Phase 2 Trial.